Biotronik, Endosense form distribution agreement

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Biotronik, a manufacturer of implantable cardiac devices and wireless remote monitoring technologies, and Endosense, a Geneva-based medical technology company, have entered into an exclusive distribution agreement for Endosense’s force-sensing ablation catheter, the TactiCath.

Under the terms of the agreement, the Berlin-based Biotronik will be the exclusive distributor of the TactiCath in most markets outside of the U.S., Japan and Asia.

Granted CE Mark for atrial fibrillation and supraventricular tachycardia indications in 2009, the TactiCath is a force-sensing ablation catheter to give physicians a measure of contact force during cardiac ablation procedures.